Stella Diagnostics (Stella Diagnostics) Short-Term Capital Lease Obligation : $0.00 Mil (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Stella Diagnostics Short-Term Capital Lease Obligation?

Stella Diagnostics's Short-Term Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.00 Mil.

Stella Diagnostics Short-Term Capital Lease Obligation Historical Data

The historical data trend for Stella Diagnostics's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Diagnostics Short-Term Capital Lease Obligation Chart

Stella Diagnostics Annual Data

Trend

Short-Term Capital Lease Obligation

Stella Diagnostics Quarterly Data
	Sep22	Sep23
Short-Term Capital Lease Obligation	-	-

Stella Diagnostics Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Stella Diagnostics Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Stella Diagnostics's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Stella Diagnostics (Stella Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Stella Diagnostics Inc (OTCPK:SLDX) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 West Broadway, Suite 300, Salt Lake City, UT, USA, 84104

Website

https://www.stelladx.com

Stella Diagnostics Inc is a molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. It is developing first-line diagnostic tools that provide superior molecular information for providers as compared to the current standard screening protocols.